Characterisation of recombinant human fatty aldehyde dehydrogenase: implications for Sjögren-Larsson syndrome

M D Lloyd, K D E Boardman, A Smith, D M van den Brink, R J A Wanders, M D Threadgill

Research output: Contribution to journal › Article › peer-review

12 Citations (SciVal)

Original language	English
Pages (from-to)	584-590
Number of pages	7
Journal	Journal of Enzyme Inhibition and Medicinal Chemistry
Volume	22
Issue number	5
Publication status	Published - 2007

Cite this

@article{fd8cff6805a04195a4b80abf6d69790a,

title = "Characterisation of recombinant human fatty aldehyde dehydrogenase: implications for Sj{\"o}gren-Larsson syndrome",

author = "Lloyd, {M D} and Boardman, {K D E} and A Smith and {van den Brink}, {D M} and Wanders, {R J A} and Threadgill, {M D}",

year = "2007",

language = "English",

volume = "22",

pages = "584--590",

journal = "Journal of Enzyme Inhibition and Medicinal Chemistry",

issn = "1475-6366",

publisher = "Informa Healthcare",

number = "5",

}

TY - JOUR

T1 - Characterisation of recombinant human fatty aldehyde dehydrogenase: implications for Sjögren-Larsson syndrome

AU - Lloyd, M D

AU - Boardman, K D E

AU - Smith, A

AU - van den Brink, D M

AU - Wanders, R J A

AU - Threadgill, M D

PY - 2007

Y1 - 2007

M3 - Article

SN - 1475-6366

VL - 22

SP - 584

EP - 590

JO - Journal of Enzyme Inhibition and Medicinal Chemistry

JF - Journal of Enzyme Inhibition and Medicinal Chemistry

IS - 5

ER -